Closing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)

Today during trading, shares of Briacell Therapeutics Corp opened at $0.92 and closed at $1.05. prices ranged from a low of $0.84 to a high of $1.05.

Share prices advanced 8.25 percent from the previous day's close of $0.97.

Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

A total of 18,762 shares was traded during the last trading day, with total trades of 35, with an average volume of 65,272 over 5 days.

Trading across the entire TSX saw 1,249 price advancers against 3,959 declines and 110 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, in the last 12 months, Briacell Therapeutics Corp's shares have plummeted -87.26%, while they have shrunken -86.54% year-to-date.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $17.74 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Briacell Therapeutics Corp is holding an average recommendation of "Strong Buy" from 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..